Clinical Approach to Ascites

Comprehensive Practical Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of ascites

Ascites represents one of the most common complications of chronic liver disease, affecting approximately 50% of patients with cirrhosis within 10 years of diagnosis. It is the leading cause of hospital admission among patients with cirrhosis and signals a significant decline in prognosis, with 1-year mortality rates of approximately 15% for uncomplicated ascites and up to 40% for refractory ascites. Beyond hepatic causes, ascites accounts for significant morbidity in malignancy, heart failure, and other conditions, making it a critical presentation for clinicians across multiple specialties to recognize and manage appropriately.

Definition

Ascites is the pathological accumulation of fluid within the peritoneal cavity. The term derives from the Greek word “askos” meaning bag or sac. Normally, the peritoneal cavity contains less than 50 milliliters of serous fluid that facilitates frictionless movement of abdominal organs. Ascites becomes clinically detectable when fluid accumulation exceeds approximately 1,500 milliliters, though smaller volumes may be detected by imaging.

Key Epidemiology

Cirrhosis accounts for approximately 85% of all cases of ascites in Western countries
Malignancy causes approximately 10% of ascites cases
Heart failure accounts for approximately 3% of cases
Other causes (tuberculosis, pancreatitis, nephrotic syndrome) comprise the remaining 2%

Classification by Volume (International Ascites Club)

Grade	Description	Detection Method	Clinical Significance
Grade 1 (Mild)	Small volume, only detectable by ultrasound	Imaging only	Often incidental finding; may not require specific treatment
Grade 2 (Moderate)	Moderate symmetrical abdominal distension	Clinical examination	Symptomatic; responds to sodium restriction and diuretics
Grade 3 (Large)	Marked abdominal distension with tense ascites	Clinical examination	Often requires therapeutic paracentesis; may indicate refractory disease

Classification by Onset and Duration

Category	Duration	Common Causes	Clinical Significance
Acute	Days to weeks	Acute liver failure, acute pancreatitis, bowel perforation, acute Budd-Chiari syndrome	Often requires urgent investigation and intervention; may indicate surgical emergency
Subacute	Weeks to months	Newly decompensated cirrhosis, malignancy, tuberculous peritonitis	Requires thorough diagnostic workup; underlying cause may be reversible
Chronic	Greater than 3 months	Established cirrhosis, chronic heart failure, nephrotic syndrome	Focus on management and prevention of complications; assess for refractory ascites

Classification by Treatment Response

Uncomplicated Ascites

Ascites that is not infected and does not meet criteria for refractory ascites. Responds to dietary sodium restriction (less than 2 grams per day) and diuretic therapy. Represents the majority of cases at initial presentation.

Refractory Ascites

Ascites that cannot be mobilized or that recurs early despite sodium restriction and maximum tolerated diuretic doses. Includes diuretic-resistant ascites (no response) and diuretic-intractable ascites (complications preclude effective diuretic use). Affects approximately 10% of patients with cirrhotic ascites.

Classification by Serum-Ascites Albumin Gradient

The Serum-Ascites Albumin Gradient (SAAG) is the single most useful test for categorizing ascites and has replaced the traditional transudate/exudate classification. It is calculated by subtracting the ascitic fluid albumin concentration from the serum albumin concentration.

SAAG Value	Interpretation	Indicates	Common Causes
≥ 1.1 g/dL (High)	Portal hypertension present	97% accuracy for portal hypertension	Cirrhosis, alcoholic hepatitis, heart failure, Budd-Chiari syndrome, portal vein thrombosis
< 1.1 g/dL (Low)	Portal hypertension absent	Non-portal hypertensive cause	Peritoneal carcinomatosis, tuberculous peritonitis, pancreatitis, nephrotic syndrome, serositis

Classification by Associated Features

Pattern	Description	Suggests
Ascites with peripheral edema	Bilateral lower extremity swelling preceding or accompanying ascites	Cirrhosis, heart failure, nephrotic syndrome (hypoalbuminemic states)
Ascites with fever and abdominal pain	Signs of peritoneal inflammation	Spontaneous bacterial peritonitis, secondary peritonitis, tuberculous peritonitis
Ascites with weight loss and cachexia	Constitutional symptoms suggesting malignancy	Peritoneal carcinomatosis, hepatocellular carcinoma
Ascites with jaundice	Yellowing of skin and sclera	Decompensated cirrhosis, acute liver failure, biliary obstruction
Bloody ascites	Red blood cell count greater than 50,000 per microliter	Malignancy (most common), traumatic tap, hepatocellular carcinoma, tuberculosis
Chylous ascites	Milky appearance with triglycerides greater than 200 mg/dL	Lymphatic obstruction (malignancy, trauma, surgery), cirrhosis with thoracic duct obstruction

Key Concept — The Dominant Cause: While the differential diagnosis of ascites is broad, cirrhosis accounts for approximately 85% of all cases in Western countries. However, approximately 5% of patients with cirrhosis have a second cause of ascites (such as peritoneal carcinomatosis or tuberculous peritonitis), emphasizing the importance of diagnostic paracentesis in all new-onset ascites regardless of known liver disease.

Impact on Quality of Life and Prognosis

Physical Impact

Abdominal distension causes early satiety, dyspnea (particularly when supine), reduced mobility, and difficulty with activities of daily living. Large-volume ascites may compress the inferior vena cava and reduce venous return.

Psychological Impact

Altered body image, social isolation, depression, and anxiety are common. Frequent hospital admissions and paracentesis procedures significantly impact quality of life.

Prognostic Significance

Development of ascites in cirrhosis marks transition from compensated to decompensated disease. Five-year survival drops from approximately 80% (compensated) to approximately 30% (decompensated with ascites).

2. Pathophysiology and Mechanisms

Understanding the underlying mechanisms of ascites formation

Ascites formation results from a complex interplay of hemodynamic, hormonal, and local factors. Understanding these mechanisms is essential for rational treatment selection and predicting response to therapy. The pathophysiology differs significantly between portal hypertensive causes (primarily cirrhosis) and non-portal hypertensive causes (such as malignancy), with important implications for management.

Normal Peritoneal Fluid Homeostasis

Component	Normal Function	Disruption in Disease
Peritoneal membrane	Semi-permeable barrier allowing passage of water and small solutes	Increased permeability in inflammation, malignancy, and infection
Splanchnic capillaries	Produce approximately 50 mL of serous fluid daily	Increased hydrostatic pressure in portal hypertension leads to transudation
Peritoneal lymphatics	Absorb peritoneal fluid; capacity approximately 800–1000 mL/day	Overwhelmed capacity or obstruction leads to fluid accumulation
Starling forces	Balance between hydrostatic and oncotic pressures maintains equilibrium	Imbalance favoring fluid extravasation causes ascites

Mechanism of Ascites in Portal Hypertension (Cirrhosis)

The peripheral arterial vasodilation hypothesis is the most widely accepted explanation for ascites formation in cirrhosis. This represents a cascade of hemodynamic and neurohumoral changes that ultimately lead to sodium and water retention.

The Peripheral Arterial Vasodilation Hypothesis — Sequential Steps:

Portal hypertension develops — Increased intrahepatic resistance and increased portal blood flow
Splanchnic vasodilation occurs — Mediated by nitric oxide and other vasodilators produced in the splanchnic circulation
Effective arterial blood volume decreases — Despite total blood volume being normal or increased, arterial underfilling occurs
Compensatory mechanisms activate — Renin-angiotensin-aldosterone system, sympathetic nervous system, and antidiuretic hormone
Sodium and water retention ensue — Kidneys retain sodium and water to compensate for perceived hypovolemia
Ascites forms — Retained fluid accumulates in the peritoneal cavity due to portal hypertension and hypoalbuminemia

Key Vasoactive Mediators and Hormonal Systems

Nitric Oxide

Role: Primary mediator of splanchnic vasodilation

Source: Endothelial cells in splanchnic circulation

Effect: Reduces systemic vascular resistance, contributes to hyperdynamic circulation

Renin-Angiotensin-Aldosterone System

Role: Activated by arterial underfilling and sympathetic stimulation

Effect: Promotes sodium retention in proximal and distal tubules; aldosterone is primary target of spironolactone therapy

Antidiuretic Hormone (Vasopressin)

Role: Released in response to non-osmotic stimuli (arterial underfilling)

Effect: Causes water retention and dilutional hyponatremia; contributes to free water excess

Factors Contributing to Ascites in Cirrhosis

Factor	Mechanism	Clinical Relevance
Portal hypertension	Increased hydrostatic pressure in splanchnic capillaries forces fluid into peritoneal cavity	SAAG ≥ 1.1 g/dL; correlates with portal pressure; threshold for ascites typically hepatic venous pressure gradient greater than 12 mmHg
Hypoalbuminemia	Reduced hepatic synthetic function decreases plasma oncotic pressure	Contributes to peripheral edema; correlates with disease severity; serum albumin less than 3.0 g/dL associated with higher risk
Splanchnic vasodilation	Reduces effective arterial blood volume, triggering sodium retention	Explains paradox of sodium retention despite total body sodium excess
Renal sodium retention	Activation of renin-angiotensin-aldosterone system and sympathetic nervous system	Target of diuretic therapy; natriuretic response predicts treatment success
Lymphatic overflow	Hepatic lymph production exceeds thoracic duct capacity	Hepatic lymph “weeps” from liver surface into peritoneal cavity

Mechanisms of Ascites Without Portal Hypertension

Malignant Ascites (Peritoneal Carcinomatosis)

Mechanism	Description	Clinical Implication
Increased peritoneal permeability	Tumor implants disrupt peritoneal membrane integrity	Protein-rich ascites (total protein typically greater than 2.5 g/dL)
Vascular endothelial growth factor production	Tumor cells secrete factors that increase vascular permeability	Explains rapid reaccumulation; may respond to targeted therapies
Lymphatic obstruction	Tumor blocks peritoneal lymphatic drainage	May cause chylous ascites if thoracic duct involved
Massive hepatic metastases	Can cause portal hypertension secondary to hepatic infiltration	May have high SAAG despite malignant cause

Cardiac Ascites

Right-Sided Heart Failure

Mechanism: Elevated central venous pressure transmitted to hepatic veins and sinusoids
Effect: Increased hepatic venous pressure causes transudation similar to cirrhosis
SAAG: High (≥ 1.1 g/dL) due to portal hypertension mechanism

Constrictive Pericarditis

Mechanism: Impaired diastolic filling raises venous pressures
Effect: Hepatic congestion and “cardiac cirrhosis” may develop
Key feature: Ascites may be disproportionate to peripheral edema

Other Non-Portal Hypertensive Mechanisms

Condition	Primary Mechanism	SAAG	Distinguishing Feature
Tuberculous peritonitis	Granulomatous inflammation increases peritoneal permeability	Low (< 1.1 g/dL)	High lymphocyte count; elevated adenosine deaminase
Nephrotic syndrome	Severe hypoalbuminemia reduces plasma oncotic pressure	Low (< 1.1 g/dL)	Heavy proteinuria; serum albumin often less than 2.0 g/dL
Pancreatic ascites	Pancreatic duct disruption leaks enzyme-rich fluid into peritoneum	Low (< 1.1 g/dL)	Very high amylase (often greater than 1000 U/L)
Chylous ascites	Disruption of lymphatic channels leaks triglyceride-rich lymph	Variable	Milky appearance; triglycerides greater than 200 mg/dL
Budd-Chiari syndrome	Hepatic venous outflow obstruction causes sinusoidal hypertension	High (≥ 1.1 g/dL)	High protein content despite high SAAG; caudate lobe hypertrophy

Summary: How Different Conditions Cause Ascites

Condition	Primary Mechanism	Treatment Implication
Cirrhosis	Portal hypertension + splanchnic vasodilation → arterial underfilling → sodium retention; lymphatic overflow	Sodium restriction and diuretics effective; target aldosterone with spironolactone
Heart failure	Elevated venous pressure → hepatic congestion → similar portal hypertension mechanism	Treat underlying cardiac disease; diuretics may help but address heart failure first
Peritoneal carcinomatosis	Increased peritoneal permeability + lymphatic obstruction; vascular endothelial growth factor-mediated leak	Diuretics usually ineffective; repeated paracentesis or indwelling catheter for palliation
Tuberculous peritonitis	Granulomatous inflammation increases peritoneal permeability	Antituberculous therapy curative; ascites resolves with treatment
Nephrotic syndrome	Severe hypoalbuminemia → decreased oncotic pressure; may have secondary hyperaldosteronism	Treat underlying renal disease; albumin infusion may help temporarily
Pancreatic ascites	Pancreatic duct disruption → direct leak of pancreatic secretions	Octreotide to reduce secretions; endoscopic or surgical intervention for duct disruption

Often Overlooked Mechanism: Mixed Ascites

Approximately 5% of patients with cirrhosis have a second cause of ascites, most commonly peritoneal carcinomatosis or tuberculous peritonitis. This “mixed ascites” may present with atypical SAAG values or unexpected ascitic fluid findings. Always consider a second diagnosis when ascites behaves unexpectedly or does not respond to appropriate therapy. Diagnostic paracentesis should be performed in all patients with new-onset ascites, even those with known cirrhosis.

Mechanism of Ascites-Related Complications

Complication	Mechanism	Clinical Significance
Spontaneous bacterial peritonitis	Bacterial translocation from gut; impaired ascitic fluid opsonic activity (low protein)	Occurs in ascites with low protein content (less than 1.0 g/dL); high mortality if untreated
Hepatorenal syndrome	Extreme splanchnic vasodilation → profound renal vasoconstriction → functional renal failure	Represents end-stage circulatory dysfunction; poor prognosis without liver transplantation
Umbilical hernia	Increased intra-abdominal pressure weakens umbilical ring	Risk of incarceration and rupture; surgical repair is high-risk in cirrhosis
Hepatic hydrothorax	Ascitic fluid crosses diaphragm through congenital defects (usually right-sided)	May cause dyspnea disproportionate to ascites volume; often refractory

3. History Taking

A comprehensive approach to eliciting the ascites history

Red Flags — Require Urgent Evaluation

Fever with abdominal pain — Spontaneous bacterial peritonitis or secondary peritonitis
Altered mental status — Hepatic encephalopathy, sepsis, or hypoglycemia
Hematemesis or melena — Variceal hemorrhage in portal hypertension
Rapid onset over days — Acute liver failure, Budd-Chiari syndrome, or malignancy

Severe abdominal pain with rigidity — Secondary peritonitis (bowel perforation)
Decreasing urine output — Hepatorenal syndrome or acute kidney injury
Hypotension or tachycardia — Sepsis, hemorrhage, or severe decompensation
New-onset jaundice with ascites — Acute liver failure or acute-on-chronic liver failure

Systematic History: The “FLUID” Approach

Use the mnemonic “FLUID” to ensure comprehensive history taking for ascites:

F — First noticed and Features: When did you first notice the swelling? How quickly did it develop? Is it painful? Have you noticed any change in size?
L — Liver and Lifestyle: Do you have known liver disease? How much alcohol do you drink (quantify in standard drinks per day/week)? Any history of hepatitis or blood transfusions? Intravenous drug use?
U — Underlying conditions and Urinary symptoms: Do you have heart failure, kidney disease, or cancer? Have you noticed changes in urine output? Any frothy urine (proteinuria)?
I — Impact and Intake: How has this affected your breathing, appetite, and daily activities? What is your typical salt and fluid intake? Have you had weight changes?
D — Drugs and Danger signs: What medications are you taking (especially NSAIDs, diuretics)? Have you had fevers, night sweats, weight loss, or abdominal pain?

Characterizing the Onset and Progression

Onset Pattern	Typical Duration	Suggests	Key Questions
Sudden (hours to days)	Less than 1 week	Acute liver failure, Budd-Chiari syndrome, bowel perforation, acute pancreatitis	“Did the swelling appear suddenly? Were you previously well?”
Rapid (days to weeks)	1–4 weeks	Malignancy, acute decompensation of cirrhosis, new-onset heart failure	“Over how many weeks did you notice the swelling increasing?”
Gradual (weeks to months)	Greater than 4 weeks	Cirrhosis, chronic heart failure, nephrotic syndrome, tuberculous peritonitis	“Has this been slowly building up over months?”
Fluctuating	Variable	Diuretic-responsive cirrhotic ascites, dietary sodium non-compliance	“Does the swelling come and go? What makes it better or worse?”

Targeted Questions by Suspected Cause

Suspected Cause	Key Features	Ask This Question
Cirrhosis (alcoholic)	History of heavy alcohol use, known liver disease, jaundice	“How much alcohol do you drink daily? For how many years? Have you ever been told you have liver problems?”
Cirrhosis (viral hepatitis)	Risk factors for hepatitis B or C, known viral infection	“Have you ever been diagnosed with hepatitis? Have you had blood transfusions before 1992, tattoos, or shared needles?”
Cirrhosis (non-alcoholic fatty liver disease)	Metabolic syndrome features, obesity, diabetes	“Do you have diabetes, high blood pressure, or high cholesterol? Have you been told you have a fatty liver?”
Heart failure	Dyspnea, orthopnea, paroxysmal nocturnal dyspnea, leg swelling preceding ascites	“Do you get short of breath lying flat? Do you wake up at night gasping for air? Did your legs swell before your abdomen?”
Malignancy	Weight loss, anorexia, known cancer history, rapid onset	“Have you had unintentional weight loss? Any history of cancer? Have you noticed any lumps or masses?”
Tuberculous peritonitis	Fever, night sweats, weight loss, endemic area exposure, immunosuppression	“Have you had fevers, drenching night sweats, or unexplained weight loss? Have you traveled to or lived in areas where tuberculosis is common?”
Nephrotic syndrome	Periorbital edema, frothy urine, known renal disease	“Have you noticed swelling around your eyes, especially in the morning? Is your urine frothy or bubbly?”
Budd-Chiari syndrome	Acute onset, right upper quadrant pain, hepatomegaly, hypercoagulable risk factors	“Did this come on very suddenly with abdominal pain? Do you have a history of blood clots? Are you taking oral contraceptives?”
Pancreatic ascites	History of pancreatitis, alcohol use, abdominal trauma	“Have you ever had pancreatitis? Any recent abdominal surgery or injury?”
Spontaneous bacterial peritonitis	Known cirrhotic ascites with new fever, abdominal pain, or encephalopathy	“Have you had a recent fever? Is your abdominal pain new or different? Have family members noticed you seem confused?”

Associated Symptoms to Explore

Symptoms Suggesting Liver Disease

Jaundice: Yellowing of skin and eyes (indicates hepatic dysfunction)
Easy bruising or bleeding: Coagulopathy from decreased clotting factors
Pruritus: Cholestatic liver disease
Confusion or sleep disturbance: Hepatic encephalopathy
Gynecomastia or testicular atrophy: Hormonal changes in cirrhosis
Dark urine and pale stools: Biliary obstruction

Symptoms Suggesting Other Causes

Dyspnea on exertion, orthopnea: Heart failure
Periorbital edema (morning): Nephrotic syndrome
Anorexia and early satiety: Malignancy or large-volume ascites
Fever and night sweats: Infection (tuberculosis, spontaneous bacterial peritonitis)
Chronic diarrhea: Protein-losing enteropathy
Postprandial abdominal pain: Mesenteric ischemia (rare cause)

Medication and Substance History

Medications That May Cause or Worsen Ascites

Nonsteroidal anti-inflammatory drugs (NSAIDs): Reduce renal prostaglandins, precipitate sodium retention and renal failure in cirrhosis
Methotrexate: Hepatotoxicity with chronic use
Amiodarone: Can cause cirrhosis with prolonged use
Oral contraceptives: Risk factor for Budd-Chiari syndrome
Calcium channel blockers: May cause peripheral edema (not true ascites)
Herbal supplements: Various hepatotoxic compounds

Current Medications to Document

Diuretics: Current doses, adherence, duration of use
Beta-blockers: For portal hypertension (non-selective)
Lactulose and rifaximin: For encephalopathy
Prophylactic antibiotics: For spontaneous bacterial peritonitis prevention
Anticoagulants: Relevant to Budd-Chiari, procedural risk
Immunosuppressants: Risk for opportunistic infections

Social and Occupational History

Factor	Relevance	Questions to Ask
Alcohol consumption	Leading cause of cirrhosis; quantify current and lifetime use	“How many drinks per day/week? What type? For how many years? Have you tried to quit?”
Intravenous drug use	Risk for hepatitis B and C	“Have you ever injected drugs? Shared needles?”
Sexual history	Hepatitis B transmission; HIV risk	“Have you had multiple sexual partners? Unprotected sex?”
Travel history	Endemic areas for hepatitis, tuberculosis, schistosomiasis	“Have you traveled to or lived in Africa, Asia, or South America?”
Occupational exposures	Vinyl chloride (hepatic angiosarcoma), healthcare workers (hepatitis)	“What is your occupation? Any exposure to chemicals or blood products?”
Dietary habits	Sodium intake affects ascites management; raw shellfish (Vibrio infection risk)	“Do you add salt to food? Eat processed foods? Do you eat raw oysters or shellfish?”
Living situation	Affects treatment compliance, home paracentesis feasibility	“Who do you live with? Can you attend regular medical appointments?”

Family History

Conditions to Ask About

Liver disease: Hemochromatosis, Wilson disease, alpha-1 antitrypsin deficiency
Autoimmune diseases: Primary biliary cholangitis, autoimmune hepatitis
Blood clotting disorders: Factor V Leiden, protein C/S deficiency (Budd-Chiari risk)
Malignancy: Especially gastrointestinal and ovarian cancers
Heart disease: Cardiomyopathy, congenital heart disease

Significance of Positive Family History

A family history of liver disease in a young patient without obvious cause should prompt investigation for hereditary conditions:

Hemochromatosis: Iron studies, HFE gene testing
Wilson disease: Ceruloplasmin, 24-hour urine copper
Alpha-1 antitrypsin deficiency: Serum alpha-1 antitrypsin level

Functional and Quality of Life Assessment

Document the impact of ascites on daily functioning:

Mobility: Can the patient walk without assistance? Climb stairs?
Breathing: Dyspnea at rest or with minimal exertion? Orthopnea?
Nutrition: Early satiety limiting oral intake? Recent weight changes?
Sleep: Disrupted by dyspnea or frequent urination from diuretics?
Work and social activities: Able to maintain employment? Social isolation?

This information helps guide treatment intensity and discussions about prognosis and goals of care.

4. Physical Examination

A systematic head-to-toe approach for ascites

Systematic Framework: Use the “General → Specific → Complications” approach for complete examination of patients presenting with ascites. Begin with general assessment, proceed to detailed abdominal examination, then systematically evaluate for signs of underlying etiology and complications.

General Inspection

Body habitus: Cachexia (malignancy, advanced cirrhosis) versus obesity (metabolic syndrome, heart failure)
Level of consciousness: Alertness, orientation, asterixis (hepatic encephalopathy)
Respiratory pattern: Tachypnea, use of accessory muscles (large-volume ascites, hepatic hydrothorax)
Skin color: Jaundice, pallor, bronze discoloration (hemochromatosis)
Nutritional status: Muscle wasting, temporal wasting (chronic liver disease, malignancy)
Position of comfort: Sitting upright (orthopnea from ascites or heart failure)

Vital Signs

Vital Sign	What to Look For	Clinical Significance
Temperature	Fever (greater than 38°C) or hypothermia	Fever suggests spontaneous bacterial peritonitis, secondary peritonitis, or other infection; hypothermia may occur in severe sepsis
Heart Rate	Tachycardia (greater than 100 beats per minute)	May indicate infection, hypovolemia (despite ascites), hyperdynamic circulation of cirrhosis, or anemia
Blood Pressure	Hypotension (systolic less than 90 mmHg) or low-normal pressures	Common in advanced cirrhosis due to vasodilation; acute drop suggests sepsis, hemorrhage, or hepatorenal syndrome
Respiratory Rate	Tachypnea (greater than 20 breaths per minute)	Large-volume ascites restricts diaphragmatic movement; consider hepatic hydrothorax or metabolic acidosis
Oxygen Saturation	Hypoxemia (less than 94% on room air)	Hepatopulmonary syndrome, hepatic hydrothorax, or concurrent pulmonary disease
Weight	Daily weight changes	Most reliable indicator of fluid balance; target weight loss of 0.5 kg/day (ascites alone) or 1 kg/day (ascites plus edema)

Stigmata of Chronic Liver Disease

Systematically examine for signs that suggest cirrhosis as the underlying cause:

Hands and Arms

Palmar erythema: Reddening of thenar and hypothenar eminences
Dupuytren’s contracture: Associated with alcoholic liver disease
Clubbing: May indicate hepatopulmonary syndrome
Leukonychia: White nails (hypoalbuminemia)
Terry’s nails: Proximal two-thirds white
Asterixis: “Liver flap” (hepatic encephalopathy)

Head and Neck

Jaundice: Best seen in sclera under natural light
Fetor hepaticus: Sweet, musty breath odor
Parotid enlargement: Alcoholic liver disease
Spider angiomata: Upper body distribution (greater than 5 is significant)
Elevated jugular venous pressure: Right heart failure, constrictive pericarditis

Trunk

Spider angiomata: Check chest, shoulders, face
Gynecomastia: Hormonal changes in cirrhosis
Loss of body hair: Chest, axillary, pubic
Caput medusae: Dilated periumbilical veins (portal hypertension)
Testicular atrophy: In males with cirrhosis

Abdominal Examination

Inspection

Abdominal distension: Generalized, symmetrical fullness; flanks may bulge when supine
Umbilicus: Everted (tense ascites); herniation; Cullen’s sign (periumbilical bruising — rare, suggests hemorrhagic ascites)
Skin changes: Striae, visible veins (direction of flow indicates portal versus caval obstruction), surgical scars
Caput medusae: Dilated veins radiating from umbilicus (blood flow away from umbilicus)
Hernias: Umbilical, inguinal (common in tense ascites due to increased intra-abdominal pressure)

Palpation

Fluid thrill: Have assistant place edge of hand on midline abdomen; tap one flank and feel impulse on opposite side. Positive with large-volume ascites (greater than 1500 mL)
Liver palpation: Hepatomegaly (congestion, malignancy, early cirrhosis) or small, hard liver (advanced cirrhosis); irregular edge suggests tumor nodules
Splenomegaly: Palpable spleen suggests portal hypertension; use ballottement technique in ascites
Tenderness: Diffuse tenderness suggests peritonitis; localized tenderness may indicate specific pathology
Masses: Palpable tumor masses, Sister Mary Joseph nodule (periumbilical metastatic deposit)

Percussion

Technique	How to Perform	Interpretation
Flank dullness	Percuss from midline laterally with patient supine	Dullness in flanks (fluid) with tympany centrally (bowel); absent flank dullness has 90% negative predictive value for ascites
Shifting dullness	Mark point where dullness begins; roll patient away from that side; re-percuss after 30 seconds	If dullness shifts toward dependent side by greater than 3 cm, ascites is likely present; most reliable bedside sign (sensitivity approximately 83%)
Puddle sign	Patient on hands and knees for 5 minutes; percuss from umbilicus toward flank	Can detect as little as 120 mL of ascites; rarely performed due to patient discomfort

Clinical Pearl: Detecting Ascites

Physical examination can reliably detect ascites when fluid volume exceeds approximately 1500 mL. For smaller volumes, ultrasound is required. The absence of flank dullness makes ascites unlikely (sensitivity approximately 94%), while the presence of shifting dullness makes ascites likely (specificity approximately 90%). When both flank dullness and shifting dullness are present, the likelihood ratio for ascites is approximately 6.

Auscultation

Bowel sounds: May be normal, hyperactive (early obstruction), or absent (peritonitis, ileus)
Venous hum: Continuous hum heard over epigastrium or near umbilicus (portal hypertension with large collaterals); Cruveilhier-Baumgarten murmur if heard over a patent paraumbilical vein
Arterial bruits: Hepatic bruit may suggest hepatocellular carcinoma or alcoholic hepatitis
Friction rub: Rare; suggests hepatic or splenic infarction, tumor involvement of liver capsule

Cardiovascular Examination

Finding	How to Assess	Clinical Significance
Jugular venous pressure	Assess at 45 degrees; measure height above sternal angle	Elevated (greater than 4 cm above sternal angle) suggests right heart failure, constrictive pericarditis, or fluid overload
Kussmaul’s sign	JVP rises paradoxically with inspiration	Suggests constrictive pericarditis or restrictive cardiomyopathy
Apex beat	Palpate in left lateral position	Displaced (cardiomegaly); heaving quality (pressure overload); difficult to locate in obesity or ascites
Heart sounds	Auscultate all areas	S3 gallop (heart failure); pericardial knock (constrictive pericarditis); murmurs (valvular disease)
Peripheral edema	Press over sacrum and lower extremities for pitting	Often accompanies ascites in cirrhosis, heart failure, and nephrotic syndrome

Respiratory Examination

Key Findings

Reduced breath sounds: At bases (pleural effusion, atelectasis from elevated diaphragm)
Dullness to percussion: Usually right-sided if hepatic hydrothorax
Decreased chest expansion: Large-volume ascites restricts diaphragm

Hepatic Hydrothorax

Occurs in 5–10% of patients with cirrhotic ascites
Right-sided in 85% of cases (diaphragmatic defects)
May cause dyspnea disproportionate to ascites volume
Can occur with minimal abdominal ascites

Lower Extremity Examination

Peripheral edema: Pitting edema of ankles, legs, and sacrum; quantify as mild, moderate, or severe (or grade 1+ to 4+)
Muscle wasting: Quadriceps atrophy (sarcopenia of chronic liver disease)
Skin changes: Stasis dermatitis, hemosiderin deposition (chronic venous insufficiency)
Deep vein thrombosis signs: Unilateral swelling, calf tenderness, warmth (hypercoagulability in malignancy, nephrotic syndrome)

Expected Findings by Etiology

Condition	General Appearance	Abdominal Findings	Other Key Findings
Cirrhosis	Cachexia, jaundice, temporal wasting	Distended abdomen, hepatosplenomegaly (early) or small liver (late), caput medusae	Spider angiomata, palmar erythema, gynecomastia, asterixis, fetor hepaticus
Heart failure	Peripheral edema preceding ascites, orthopnea	Tender hepatomegaly (congestive hepatopathy), hepatojugular reflux positive	Elevated JVP, S3 gallop, bilateral pleural effusions, peripheral edema greater than ascites
Malignancy	Cachexia, lymphadenopathy, palpable masses	Hard, irregular hepatomegaly; Sister Mary Joseph nodule; palpable omental cake	Left supraclavicular node (Virchow’s node), pelvic mass on rectal examination
Tuberculous peritonitis	Fever, weight loss, night sweats	Doughy feel to abdomen; diffuse tenderness; hepatosplenomegaly	Lymphadenopathy, pulmonary signs if concurrent tuberculosis
Nephrotic syndrome	Periorbital edema (especially morning), anasarca	Ascites may be less prominent than peripheral edema	Frothy urine (if observed), edema in dependent areas
Budd-Chiari syndrome	Acute illness, right upper quadrant pain	Tender hepatomegaly (may be massive), caudate lobe hypertrophy (difficult to palpate)	Rapid onset; dilated abdominal wall veins with upward flow

Important Teaching Point

Physical examination has limitations! While stigmata of chronic liver disease strongly suggest cirrhosis as the cause, their absence does not exclude it — approximately 30% of patients with compensated cirrhosis have no physical findings. Additionally, small-volume ascites (less than 1500 mL) cannot be reliably detected on examination. Ultrasound is more sensitive for detecting both ascites and hepatic parenchymal changes. Always proceed to diagnostic paracentesis in new-onset ascites regardless of physical findings.

Special Examination Maneuvers

Maneuver	Technique	Interpretation
Hepatojugular reflux	Apply firm pressure over liver for 30–60 seconds while observing JVP	Sustained rise in JVP greater than 3 cm suggests right heart failure or constrictive pericarditis
Ballottement of liver/spleen	In the presence of ascites, use quick dipping motion to displace fluid and palpate organ	Allows assessment of liver and spleen size when ascites obscures standard palpation
Auscultatory percussion of liver span	Place stethoscope over liver; scratch lightly from periphery toward liver	Sound quality changes over liver edge; useful when ascites makes standard percussion difficult
Test for asterixis	Ask patient to extend arms, dorsiflex wrists, and spread fingers for 30 seconds	Flapping tremor indicates hepatic encephalopathy; also seen in uremia, carbon dioxide retention

5. Differential Diagnosis

Systematic approach organized by probability and clinical features

The differential diagnosis of ascites is best organized using the Serum-Ascites Albumin Gradient (SAAG), which categorizes causes based on the presence or absence of portal hypertension. This approach has 97% accuracy in distinguishing portal hypertensive from non-portal hypertensive causes and directly guides further investigation and management.

High SAAG Ascites (≥ 1.1 g/dL) — Portal Hypertension Present

Probability	Condition	Key Features	Red Flags
COMMON (approximately 85%)	Cirrhosis (all causes)	Stigmata of chronic liver disease, hepatosplenomegaly, history of liver disease or risk factors	Fever, abdominal pain (spontaneous bacterial peritonitis); altered mental status (encephalopathy); gastrointestinal bleeding
LESS COMMON (approximately 10%)	Cardiac ascites (heart failure, constrictive pericarditis)	Elevated jugular venous pressure, peripheral edema preceding ascites, S3 gallop, history of cardiac disease	Acute decompensation; new arrhythmia; chest pain
LESS COMMON	Alcoholic hepatitis (without established cirrhosis)	Recent heavy alcohol use, fever, tender hepatomegaly, leukocytosis, elevated bilirubin	Maddrey discriminant function greater than 32 indicates severe disease
UNCOMMON BUT SERIOUS (approximately 3%)	Budd-Chiari syndrome (hepatic vein thrombosis)	Acute onset, right upper quadrant pain, tender hepatomegaly, hypercoagulable risk factors	Fulminant presentation; acute liver failure; known myeloproliferative disorder
UNCOMMON BUT SERIOUS	Portal vein thrombosis	May be acute (abdominal pain, bloody diarrhea) or chronic (incidental finding, varices without cirrhosis)	Mesenteric ischemia signs; fever suggesting pylephlebitis
UNCOMMON BUT SERIOUS	Sinusoidal obstruction syndrome (veno-occlusive disease)	History of bone marrow transplant or chemotherapy, tender hepatomegaly, weight gain, jaundice	Occurs within 30 days of transplant; multi-organ failure
UNCOMMON	Massive hepatic metastases	Known primary malignancy, hard irregular hepatomegaly, weight loss	Rapid progression; liver failure
RARE	Myxedema (severe hypothyroidism)	Features of hypothyroidism, high protein ascites despite high SAAG	Myxedema coma

Low SAAG Ascites (< 1.1 g/dL) — Portal Hypertension Absent

Probability	Condition	Key Features	Red Flags
MOST COMMON IN THIS CATEGORY (approximately 50%)	Peritoneal carcinomatosis	Weight loss, anorexia, known malignancy (ovarian, gastric, colon, pancreatic), palpable masses	Rapid accumulation; bloody ascites; bowel obstruction
LESS COMMON (approximately 20%)	Tuberculous peritonitis	Fever, night sweats, weight loss, endemic area exposure, immunosuppression (HIV)	Concurrent pulmonary tuberculosis; disseminated disease
LESS COMMON	Pancreatic ascites	History of pancreatitis or pancreatic surgery, abdominal pain, very high ascitic amylase	Pancreatic necrosis; pseudocyst rupture
LESS COMMON	Nephrotic syndrome	Severe hypoalbuminemia, periorbital and peripheral edema, frothy urine, heavy proteinuria	Renal vein thrombosis; acute kidney injury
UNCOMMON	Serositis (systemic lupus erythematosus, rheumatoid arthritis)	Known autoimmune disease, polyserositis (pleural and pericardial effusions), arthritis	Lupus flare; concurrent nephritis
UNCOMMON	Bowel obstruction or infarction	Acute abdomen, absent bowel sounds, distension, peritoneal signs	Surgical emergency; strangulation; perforation
UNCOMMON	Biliary ascites (bile leak)	Recent biliary surgery or trauma, jaundice, very high ascitic bilirubin	Biliary peritonitis; sepsis
RARE	Peritoneal mesothelioma	Asbestos exposure history, abdominal pain, weight loss	Often presents late; poor prognosis

Special Categories of Ascites

Step-by-Step Approach to Ascites Classification:

Step 1: Perform diagnostic paracentesis — Calculate SAAG to determine if portal hypertension is present
Step 2: If high SAAG — Evaluate for cirrhosis (most common), then cardiac causes, then vascular causes
Step 3: If low SAAG — Evaluate for malignancy (most common in this category), infection, or other causes
Step 4: Use ascitic fluid total protein to further refine diagnosis within SAAG categories

Chylous Ascites

Cause Category	Examples	Mechanism	Key Features
Malignancy (most common in adults)	Lymphoma, metastatic carcinoma	Lymphatic obstruction by tumor	Weight loss, lymphadenopathy, progressive course
Cirrhosis	Advanced portal hypertension	Rupture of dilated lymphatics; thoracic duct obstruction	Known cirrhosis, other stigmata of liver disease
Surgical or traumatic	Post-abdominal surgery, lymph node dissection	Direct lymphatic injury	Recent surgery or trauma; often self-limiting
Infectious	Tuberculosis, filariasis	Lymphatic inflammation and obstruction	Endemic area; systemic symptoms
Congenital	Lymphatic malformations	Abnormal lymphatic development	Presents in childhood or young adulthood

Bloody Ascites (Red Blood Cell Count Greater Than 50,000/μL)

Common Causes

Malignancy: Most common cause of truly bloody ascites
Hepatocellular carcinoma: Tumor rupture or invasion
Traumatic paracentesis: Usually clears with continued drainage

Less Common Causes

Tuberculous peritonitis: May cause bloody ascites
Ruptured ectopic pregnancy: In women of childbearing age
Abdominal trauma: Splenic or hepatic injury

Anatomical Approach to Ascites

Hepatic Causes

Cirrhosis (all causes)

Alcoholic hepatitis

Acute liver failure

Hepatocellular carcinoma

Massive hepatic metastases

Budd-Chiari syndrome

Cardiac Causes

Right-sided heart failure

Constrictive pericarditis

Tricuspid regurgitation

Restrictive cardiomyopathy

Cor pulmonale

Peritoneal Causes

Peritoneal carcinomatosis

Tuberculous peritonitis

Secondary bacterial peritonitis

Peritoneal mesothelioma

Serositis (lupus, rheumatoid)

Other Causes

Nephrotic syndrome

Pancreatic ascites

Biliary ascites

Chylous ascites

Myxedema

Ovarian disease (Meigs syndrome)

Etiologies of Cirrhosis (When Cirrhosis Is Identified)

Cause	Approximate Frequency	Key Diagnostic Clues	Confirmatory Tests
Alcohol-related liver disease	30–40%	History of heavy drinking (greater than 40 g/day women, greater than 60 g/day men), AST:ALT ratio greater than 2	Clinical history; exclusion of other causes
Chronic hepatitis C	25–30%	Risk factors (transfusions pre-1992, injection drug use), often asymptomatic until cirrhosis	Hepatitis C antibody, HCV RNA
Non-alcoholic steatohepatitis	15–20% (increasing)	Metabolic syndrome, obesity, diabetes, often “cryptogenic” cirrhosis	Exclusion of other causes; may have steatosis on imaging
Chronic hepatitis B	10–15%	Endemic area origin, vertical transmission, known chronic infection	Hepatitis B surface antigen, HBV DNA
Autoimmune hepatitis	5%	Female predominance, other autoimmune diseases, elevated immunoglobulins	ANA, anti-smooth muscle antibody, elevated IgG
Primary biliary cholangitis	2–3%	Middle-aged women, pruritus, fatigue, elevated alkaline phosphatase	Anti-mitochondrial antibody (AMA)
Hemochromatosis	2–3%	Bronze skin, diabetes, arthropathy, family history	Elevated ferritin and transferrin saturation, HFE gene testing
Wilson disease	Rare (younger patients)	Age less than 40, neuropsychiatric symptoms, Kayser-Fleischer rings	Low ceruloplasmin, elevated 24-hour urine copper
Alpha-1 antitrypsin deficiency	Rare	Early-onset emphysema, family history, Northern European ancestry	Serum alpha-1 antitrypsin level, phenotype testing

Drug-Induced Ascites and Liver Disease

Drug or Drug Class	Mechanism	Characteristics	Management
Methotrexate	Direct hepatotoxicity with chronic use	Cirrhosis develops insidiously; cumulative dose-dependent	Discontinue; liver biopsy to assess fibrosis
Amiodarone	Phospholipidosis and steatohepatitis	Can cause cirrhosis; resembles alcoholic liver disease histologically	Discontinue; long half-life means slow resolution
Isoniazid	Idiosyncratic hepatotoxicity	Can cause acute liver failure; rarely progresses to cirrhosis	Discontinue immediately if hepatotoxicity develops
Oral contraceptives	Hypercoagulability causing Budd-Chiari syndrome	Acute presentation with hepatomegaly, ascites, abdominal pain	Discontinue; anticoagulation; possible intervention
Chemotherapy (various agents)	Sinusoidal obstruction syndrome; direct hepatotoxicity	Occurs after bone marrow transplant or certain chemotherapy regimens	Supportive care; defibrotide for sinusoidal obstruction syndrome
Nonsteroidal anti-inflammatory drugs	Do not cause ascites but worsen it in cirrhosis (reduce renal prostaglandins)	Sodium retention, renal impairment, diuretic resistance	Avoid in all patients with cirrhotic ascites

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Next Step
High SAAG + low ascitic protein (less than 2.5 g/dL)	Cirrhosis	Evaluate for cirrhosis etiology; high risk for spontaneous bacterial peritonitis
High SAAG + high ascitic protein (greater than 2.5 g/dL)	Cardiac ascites or Budd-Chiari syndrome	Echocardiogram; hepatic vein Doppler ultrasound
Low SAAG + high ascitic protein	Peritoneal carcinomatosis or tuberculous peritonitis	Ascitic fluid cytology; adenosine deaminase; CT imaging; consider laparoscopy
Milky (chylous) ascites	Lymphatic obstruction (malignancy most common)	Ascitic fluid triglycerides; CT abdomen for lymphadenopathy/mass
Bloody ascites + weight loss	Malignancy (especially hepatocellular carcinoma)	CT or MRI; tumor markers (AFP); ascitic fluid cytology
Ascites + fever + abdominal pain in known cirrhotic	Spontaneous bacterial peritonitis	Urgent paracentesis; start empiric antibiotics if polymorphonuclear cells greater than 250/μL
Ascites + elevated jugular venous pressure + peripheral edema	Cardiac ascites (heart failure or constrictive pericarditis)	Echocardiogram; BNP/NT-proBNP
Ascitic amylase greater than 1000 U/L	Pancreatic ascites	CT pancreas; MRCP; evaluate for pancreatic duct disruption
Ascites + periorbital edema + frothy urine	Nephrotic syndrome	Urinalysis (proteinuria); spot urine protein:creatinine ratio; serum albumin
Acute onset + tender hepatomegaly + hypercoagulable risk	Budd-Chiari syndrome	Hepatic vein Doppler; CT/MRI with venous phase; thrombophilia workup

Don’t Forget: Mixed Ascites

Approximately 5% of patients with cirrhosis have a second cause of ascites. Consider this possibility when:

Ascites does not respond to appropriate diuretic therapy
Ascitic fluid analysis shows unexpected findings (very high protein, positive cytology, very high lymphocyte count)
Patient has risk factors for a second condition (known malignancy, tuberculosis exposure)
Clinical course is atypical for cirrhotic ascites

6. Diagnostic Investigations

A stepwise, cost-effective approach guided by clinical suspicion

The cornerstone of ascites evaluation is diagnostic paracentesis with ascitic fluid analysis. This should be performed in all patients with new-onset ascites, all patients admitted to hospital with ascites, and any patient with ascites who develops clinical deterioration. Additional investigations are guided by the ascitic fluid results and clinical suspicion.

Diagnostic Paracentesis — The Essential First Step

Indications for Diagnostic Paracentesis

All new-onset ascites — To determine etiology
All hospital admissions with ascites — To exclude spontaneous bacterial peritonitis
Clinical deterioration — Fever, abdominal pain, encephalopathy, renal function decline, gastrointestinal bleeding
Before starting antibiotic therapy — To obtain culture before antibiotics whenever possible

Note: There are virtually no absolute contraindications. Coagulopathy and thrombocytopenia are common in cirrhosis but do not preclude paracentesis. Routine correction of coagulation parameters is not required.

Ascitic Fluid Analysis

Routine Tests (Order in All Cases)

Test	Purpose	Key Values and Interpretation	Practical Points
Cell count and differential	Diagnose spontaneous bacterial peritonitis	Polymorphonuclear cells ≥ 250/μL = spontaneous bacterial peritonitis (even if culture negative)	Most important test for infection; results available within hours
Albumin	Calculate SAAG	SAAG = Serum albumin − Ascitic albumin; ≥ 1.1 g/dL indicates portal hypertension	Must draw serum albumin simultaneously; 97% accuracy for portal hypertension
Total protein	Further classify cause; assess spontaneous bacterial peritonitis risk	Less than 1.0 g/dL = high risk for spontaneous bacterial peritonitis; greater than 2.5 g/dL suggests cardiac or Budd-Chiari	Use with SAAG for more specific diagnosis
Culture (aerobic and anaerobic)	Identify causative organism	Positive in approximately 40% of spontaneous bacterial peritonitis cases	Inoculate at bedside into blood culture bottles (10 mL each); sensitivity increases 3-fold
Glucose	Distinguish spontaneous from secondary bacterial peritonitis	Less than 50 mg/dL suggests secondary peritonitis or tuberculosis	Bacteria and neutrophils consume glucose

Additional Tests (Order Based on Clinical Suspicion)

Test	When to Order	Key Values and Interpretation
Cytology	Suspected malignancy; low SAAG ascites	Sensitivity approximately 60–90% for peritoneal carcinomatosis; may require large volume (50–200 mL)
Adenosine deaminase (ADA)	Suspected tuberculous peritonitis	Greater than 40 U/L suggests tuberculosis (sensitivity approximately 90%); lower cutoff in cirrhosis
Amylase	Suspected pancreatic ascites or gut perforation	Greater than 1000 U/L suggests pancreatic source; elevated in gut perforation
Lactate dehydrogenase (LDH)	Distinguish spontaneous from secondary bacterial peritonitis	Ascitic LDH greater than serum upper limit suggests secondary peritonitis or malignancy
Bilirubin	Suspected biliary leak; dark brown ascites	Ascitic bilirubin greater than serum bilirubin indicates biliary source
Triglycerides	Milky (chylous) appearance	Greater than 200 mg/dL confirms chylous ascites; often greater than 1000 mg/dL
Gram stain	Suspected infection	Low sensitivity (approximately 10%); more useful in secondary peritonitis
Acid-fast bacilli smear and culture	Suspected tuberculosis	Very low sensitivity; culture takes weeks; peritoneal biopsy more definitive
Carcinoembryonic antigen (CEA) and alkaline phosphatase	Distinguish spontaneous from secondary bacterial peritonitis	CEA greater than 5 ng/mL or alkaline phosphatase greater than 240 U/L suggests gut perforation

Interpreting SAAG with Total Protein

SAAG	Total Protein	Most Likely Diagnoses
High (≥ 1.1 g/dL)	Low (less than 2.5 g/dL)	Cirrhosis (most common scenario)
High (≥ 1.1 g/dL)	High (greater than 2.5 g/dL)	Cardiac ascites, Budd-Chiari syndrome, early/mixed cirrhosis
Low (< 1.1 g/dL)	High (greater than 2.5 g/dL)	Peritoneal carcinomatosis, tuberculous peritonitis, pancreatic ascites
Low (< 1.1 g/dL)	Low (less than 2.5 g/dL)	Nephrotic syndrome (rare presentation as ascites)

Blood Investigations

Baseline Tests for All Patients with Ascites

Investigation	Purpose	Key Findings
Complete blood count	Assess for anemia, infection, hypersplenism	Thrombocytopenia (less than 150,000/μL) suggests portal hypertension; leukocytosis suggests infection
Comprehensive metabolic panel	Liver function, renal function, electrolytes	Elevated bilirubin, low albumin, elevated creatinine (hepatorenal syndrome risk); hyponatremia common
Coagulation studies (PT/INR)	Assess synthetic function	Prolonged in cirrhosis; used in prognostic scores (Child-Pugh, MELD)
Serum albumin	Calculate SAAG; assess synthetic function	Required simultaneously with ascitic albumin; low levels indicate advanced liver disease

Tests to Determine Cirrhosis Etiology

First-Line Tests

Hepatitis B serology: Surface antigen, core antibody, surface antibody
Hepatitis C antibody: If positive, confirm with HCV RNA
Iron studies: Ferritin, transferrin saturation (hemochromatosis screen)
Autoimmune markers: ANA, anti-smooth muscle antibody, immunoglobulin levels

Second-Line Tests (If First-Line Negative)

Ceruloplasmin: Wilson disease (especially if age less than 40)
Alpha-1 antitrypsin level: Alpha-1 antitrypsin deficiency
Anti-mitochondrial antibody: Primary biliary cholangitis
HFE gene testing: If iron studies elevated

Imaging Studies

Modality	Indications	What It Shows	Limitations
Abdominal ultrasound with Doppler	First-line imaging for all ascites; assess for portal hypertension	Ascites (detects as little as 100 mL), liver size and texture, splenomegaly, portal vein patency, hepatic vein flow	Operator-dependent; limited by body habitus and bowel gas
Computed tomography (CT) abdomen and pelvis	Suspected malignancy, unclear diagnosis, planning intervention	Masses, lymphadenopathy, peritoneal nodules, vascular abnormalities, pancreatic pathology	Radiation exposure; contrast contraindicated if renal impairment severe
Magnetic resonance imaging (MRI) with MRCP	Characterize liver lesions, biliary evaluation, Budd-Chiari syndrome	Detailed liver parenchyma, hepatocellular carcinoma characterization, biliary anatomy, vascular patency	Expensive; longer imaging time; contraindicated with some implants
Echocardiography	Suspected cardiac cause; elevated jugular venous pressure	Ejection fraction, valvular disease, pericardial disease, right heart function	May not detect constrictive pericarditis well; CT or MRI may be needed
Chest radiograph	Baseline in all; assess for pleural effusion	Pleural effusion (hepatic hydrothorax typically right-sided), cardiomegaly, pulmonary pathology	Limited sensitivity for small effusions

Targeted Investigations by Suspected Etiology

If Suspecting Spontaneous Bacterial Peritonitis

Diagnostic Criteria

Ascitic fluid polymorphonuclear cells ≥ 250/μL — Diagnostic, even with negative culture
Positive ascitic fluid culture — Confirms diagnosis; guides antibiotic selection
No evidence of intra-abdominal surgical source — Distinguishes from secondary peritonitis

Exclude Secondary Peritonitis If:

Ascitic glucose less than 50 mg/dL
Ascitic LDH greater than serum upper limit
Ascitic total protein greater than 1 g/dL
Multiple organisms on culture
Poor response to antibiotics at 48 hours

If Suspecting Malignancy

Initial Workup

Ascitic fluid cytology: Submit 50–200 mL for highest sensitivity
CT chest, abdomen, and pelvis: Identify primary tumor, staging
Tumor markers: CA-125 (ovarian), CEA (gastrointestinal), CA 19-9 (pancreatic), AFP (hepatocellular carcinoma)

If Initial Workup Negative

Repeat cytology: Sensitivity increases with multiple samples
Diagnostic laparoscopy with peritoneal biopsy: Gold standard for peritoneal carcinomatosis
PET-CT: May identify occult primary

If Suspecting Tuberculous Peritonitis

Ascitic Fluid Tests

Adenosine deaminase: Greater than 40 U/L (lower cutoff if cirrhosis present)
Lymphocyte predominance: Greater than 70% lymphocytes
Acid-fast bacilli smear and culture: Low sensitivity; culture takes 4–8 weeks
Mycobacterial PCR: Variable sensitivity

Additional Tests

Chest radiograph: Concurrent pulmonary tuberculosis in approximately 30%
Tuberculin skin test or interferon-gamma release assay: Supports diagnosis but does not confirm peritoneal involvement
Laparoscopy with peritoneal biopsy: Gold standard; shows characteristic “millet seed” nodules

If Suspecting Cardiac Cause

Test	Purpose	Key Findings
Brain natriuretic peptide (BNP) or NT-proBNP	Screen for heart failure	Elevated (greater than 400 pg/mL for BNP) suggests cardiac cause; may be elevated in cirrhosis too
Transthoracic echocardiogram	Assess cardiac structure and function	Reduced ejection fraction, valvular disease, pericardial thickening, right heart dilation
Cardiac CT or MRI	Evaluate for constrictive pericarditis	Pericardial thickening (greater than 4 mm), calcification, septal bounce
Right heart catheterization	Confirm constrictive pericarditis	Elevated and equalized diastolic pressures; “square root” sign

Prognostic Assessment in Cirrhosis

Score	Components	Purpose
Child-Pugh Score	Bilirubin, albumin, INR, ascites, encephalopathy (each scored 1–3)	Class A (5–6), B (7–9), C (10–15); guides prognosis and surgical risk
MELD Score (Model for End-Stage Liver Disease)	Bilirubin, creatinine, INR, sodium (MELD-Na)	Predicts 90-day mortality; used for transplant allocation
MELD-Na Score	MELD plus serum sodium	Better predictor than MELD alone; used in transplant listing

When Initial Workup Is Non-Diagnostic

If ascitic fluid analysis and initial imaging do not reveal a clear diagnosis:

Repeat paracentesis: Cell counts and cytology may vary; consider larger volume for cytology
Diagnostic laparoscopy: Gold standard for peritoneal disease; allows direct visualization and biopsy
Empiric anti-tuberculosis therapy: May be considered in high-risk patients while awaiting definitive diagnosis, particularly in endemic areas
Trial of diuretics: Response to diuretics suggests portal hypertensive cause even if SAAG is borderline

7. Pattern Recognition and Clinical Decision-Making

Practical algorithms and decision pathways

Step 1: Is This Urgent?

Clinical Scenario	Urgency Level	Immediate Action
Fever, abdominal pain, and/or altered mental status in patient with ascites	EMERGENT	Immediate paracentesis; start empiric antibiotics (cefotaxime or ceftriaxone) if polymorphonuclear cells ≥ 250/μL; do not wait for culture
Hematemesis or melena with ascites	EMERGENT	Resuscitation; urgent endoscopy; octreotide infusion; prophylactic antibiotics; ICU admission
Tense ascites with respiratory distress	EMERGENT	Therapeutic paracentesis (large-volume); provide albumin if removing greater than 5 liters
Rapidly progressive ascites over days with abdominal pain	URGENT	Diagnostic paracentesis; hepatic vein Doppler to exclude Budd-Chiari syndrome; CT if malignancy suspected
New-onset ascites with jaundice and coagulopathy	URGENT	Evaluate for acute liver failure versus acute-on-chronic liver failure; early hepatology and transplant consultation
Rising creatinine in patient with cirrhotic ascites	URGENT	Hold diuretics; volume challenge with albumin; rule out infection; consider hepatorenal syndrome
New-onset ascites, stable patient	ROUTINE	Diagnostic paracentesis; calculate SAAG; initiate workup based on results
Known cirrhotic with gradual increase in ascites	ROUTINE	Assess dietary compliance; adjust diuretics; consider paracentesis if symptomatic

Step 2: Initial Assessment Algorithm

All Patients with New-Onset Ascites:

Perform diagnostic paracentesis — Send cell count, albumin, total protein, culture
Calculate SAAG — Serum albumin minus ascitic albumin
Classify as high SAAG (≥ 1.1 g/dL) or low SAAG (< 1.1 g/dL)
Order additional tests based on clinical suspicion
Obtain abdominal ultrasound with Doppler

Step 3: Follow the SAAG-Based Pathway

Algorithm A: High SAAG Ascites (≥ 1.1 g/dL)

Clinical Scenario	Most Likely Diagnosis	Action
Stigmata of chronic liver disease + low ascitic protein (less than 2.5 g/dL)	Cirrhosis	Determine cirrhosis etiology; start sodium restriction and diuretics; screen for hepatocellular carcinoma
Elevated jugular venous pressure + peripheral edema + high ascitic protein (greater than 2.5 g/dL)	Cardiac ascites	Echocardiogram; BNP; treat underlying heart failure; diuretics may help
Acute onset + tender hepatomegaly + high ascitic protein + hypercoagulable risk	Budd-Chiari syndrome	Urgent hepatic vein Doppler; CT/MRI; anticoagulation; consider intervention (TIPS, thrombolysis)
Recent heavy alcohol use + fever + leukocytosis + AST:ALT greater than 2	Alcoholic hepatitis	Calculate Maddrey discriminant function; consider corticosteroids if severe; alcohol cessation support
Polymorphonuclear cells ≥ 250/μL in ascitic fluid	Spontaneous bacterial peritonitis	Start empiric antibiotics immediately; do not wait for culture; repeat paracentesis at 48 hours

Algorithm B: Low SAAG Ascites (< 1.1 g/dL)

Clinical Scenario	Most Likely Diagnosis	Action
Weight loss + known malignancy + high ascitic protein	Peritoneal carcinomatosis	Ascitic cytology; CT staging; tumor markers; palliative care referral
Fever + night sweats + endemic area exposure + lymphocyte-predominant ascites	Tuberculous peritonitis	Adenosine deaminase level; consider laparoscopy with peritoneal biopsy; start anti-tuberculosis therapy if high suspicion
History of pancreatitis + very high ascitic amylase (greater than 1000 U/L)	Pancreatic ascites	CT pancreas; MRCP; consider octreotide; surgical or endoscopic intervention for duct disruption
Periorbital edema + frothy urine + serum albumin less than 2.0 g/dL	Nephrotic syndrome	24-hour urine protein; renal biopsy if indicated; treat underlying glomerular disease
Known autoimmune disease + polyserositis	Serositis (lupus, rheumatoid)	Autoimmune serologies; treat underlying disease; corticosteroids or immunosuppression

Spontaneous Bacterial Peritonitis: Critical Decision Points

Spontaneous Bacterial Peritonitis Management Algorithm

Diagnose: Ascitic fluid polymorphonuclear cells ≥ 250/μL (do not wait for culture)
Treat immediately: Cefotaxime 2 g IV every 8 hours (or ceftriaxone 2 g IV daily) for 5 days
Prevent hepatorenal syndrome: Albumin 1.5 g/kg on day 1 and 1 g/kg on day 3 (if creatinine greater than 1 mg/dL, BUN greater than 30 mg/dL, or bilirubin greater than 4 mg/dL)
Assess response: Repeat paracentesis at 48 hours; polymorphonuclear cells should decrease by ≥ 25%
If no response: Broaden antibiotics; consider secondary peritonitis (CT imaging)
Secondary prophylaxis: Norfloxacin 400 mg daily or trimethoprim-sulfamethoxazole after recovery

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
Patient on diuretics develops rising creatinine	Hold diuretics immediately; check for infection; give albumin challenge (1 g/kg)	If creatinine does not improve with volume, consider hepatorenal syndrome; nephrology consult
Ascites not responding to maximum diuretics	Confirm sodium restriction compliance (spot urine sodium should be greater than potassium); rule out spontaneous bacterial peritonitis	Consider refractory ascites; evaluate for TIPS or serial large-volume paracentesis; transplant evaluation
Paracentesis yields bloody fluid	Check if traumatic tap (usually clears); if persistently bloody, consider malignancy	Send cytology; check hematocrit of fluid; CT imaging if hepatocellular carcinoma or malignancy suspected
Paracentesis yields milky fluid	Send triglyceride level (chylous if greater than 200 mg/dL)	Evaluate for lymphatic obstruction (malignancy most common); CT for lymphadenopathy; dietary modification (medium-chain triglycerides)
Patient with cirrhotic ascites develops confusion	Perform paracentesis to rule out spontaneous bacterial peritonitis; check ammonia; assess for precipitants	Treat hepatic encephalopathy (lactulose, rifaximin); address underlying trigger (infection, bleeding, constipation)
Ascites recurs rapidly after paracentesis	Reassess sodium restriction compliance; optimize diuretics	If truly refractory, consider TIPS evaluation; indwelling peritoneal catheter for palliative cases
SAAG is borderline (around 1.1 g/dL)	Repeat paracentesis; consider mixed ascites (two causes)	Pursue workup for both portal hypertensive and non-portal hypertensive causes
Ascitic cytology negative but malignancy still suspected	Repeat cytology with larger volume (100–200 mL)	If still negative, diagnostic laparoscopy with peritoneal biopsy is gold standard

Diuretic Management Algorithm for Cirrhotic Ascites

Step	Action	Monitoring
1. Sodium restriction	Limit to less than 2 grams (88 mmol) sodium per day	Dietary counseling; spot urine sodium to assess compliance
2. Initial diuretic therapy	Spironolactone 100 mg + furosemide 40 mg daily (100:40 ratio)	Daily weight; goal weight loss 0.5 kg/day (ascites only) or 1 kg/day (ascites plus edema)
3. Titrate diuretics	Increase every 3–5 days maintaining 100:40 ratio (maximum: spironolactone 400 mg, furosemide 160 mg)	Creatinine, potassium, sodium every 1–2 weeks during titration
4. Assess response	If no response at maximum doses: confirm sodium restriction; rule out spontaneous bacterial peritonitis	Spot urine sodium greater than urine potassium indicates adequate natriuresis
5. Refractory ascites	Consider serial large-volume paracentesis with albumin; TIPS evaluation; transplant referral	Monitor for hepatorenal syndrome, encephalopathy, nutritional decline

Troubleshooting Refractory Ascites

Ask These Questions When Ascites Does Not Respond

Is sodium restriction adequate? — Spot urine sodium should exceed urine potassium if compliant
Is diuretic dose adequate? — Titrate to maximum tolerated doses before declaring refractory
Is there unrecognized spontaneous bacterial peritonitis? — Repeat paracentesis
Is the diagnosis correct? — Reconsider if low SAAG or atypical features
Is there a second cause of ascites? — Mixed ascites in approximately 5% of cirrhotics
Has hepatocellular carcinoma developed? — Screening ultrasound if not done recently
Is portal vein thrombosis present? — Doppler ultrasound to assess patency
Is the patient taking NSAIDs? — These cause diuretic resistance and should be stopped

When to Refer

Hepatology/Gastroenterology Referral

All new diagnoses of cirrhosis
Refractory ascites not responding to maximal medical therapy
Consideration for TIPS procedure
Liver transplant evaluation
Recurrent spontaneous bacterial peritonitis
Hepatocellular carcinoma

Other Specialty Referrals

Cardiology: Cardiac ascites, constrictive pericarditis
Oncology: Peritoneal carcinomatosis, malignant ascites
Infectious disease: Tuberculous peritonitis
Interventional radiology: TIPS, portal vein intervention
Surgery: Secondary peritonitis, symptomatic umbilical hernia (high risk)
Palliative care: Refractory malignant ascites, end-stage liver disease not transplant candidates

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

SAAG is the single most useful test: The Serum-Ascites Albumin Gradient has 97% accuracy in distinguishing portal hypertensive from non-portal hypertensive causes. Always calculate it in new-onset ascites.

Always do a diagnostic paracentesis: Perform paracentesis in all new-onset ascites, all hospital admissions with ascites, and any clinical deterioration. It is safe even with coagulopathy and thrombocytopenia — routine correction is not needed.

Spontaneous bacterial peritonitis can be subtle: Classic symptoms (fever, abdominal pain) are absent in up to one-third of cases. Always paracentesis if a cirrhotic patient deteriorates, even without obvious signs of infection.

Treat spontaneous bacterial peritonitis empirically: Start antibiotics immediately if ascitic polymorphonuclear cells ≥ 250/μL. Do not wait for culture results — mortality increases with delayed treatment.

Albumin prevents hepatorenal syndrome in spontaneous bacterial peritonitis: Administer albumin 1.5 g/kg on day 1 and 1 g/kg on day 3 for high-risk patients (creatinine greater than 1 mg/dL, BUN greater than 30 mg/dL, or bilirubin greater than 4 mg/dL).

Use the 100:40 ratio for diuretics: Spironolactone and furosemide at a 100:40 mg ratio (e.g., 100 mg:40 mg, 200 mg:80 mg) maintains potassium balance and maximizes natriuresis.

High SAAG plus high protein suggests cardiac or Budd-Chiari: Cirrhosis typically has low ascitic protein (less than 2.5 g/dL). If protein is high despite high SAAG, consider cardiac ascites or hepatic venous outflow obstruction.

Inoculate culture bottles at bedside: Placing 10 mL of ascitic fluid into blood culture bottles at the bedside increases culture sensitivity from approximately 40% to approximately 80%.

Critical Pitfalls to Avoid

Skipping paracentesis because of coagulopathy: There is no safe INR or platelet threshold. Bleeding complications are rare (less than 1%) even with significant coagulopathy. Do not transfuse products prophylactically.

Using only culture to diagnose spontaneous bacterial peritonitis: Cultures are negative in up to 60% of cases. Diagnosis is based on polymorphonuclear cells ≥ 250/μL — treat empirically regardless of culture result.

Prescribing NSAIDs to patients with cirrhotic ascites: NSAIDs reduce renal prostaglandins, causing sodium retention, diuretic resistance, and acute kidney injury. They are absolutely contraindicated.

Forgetting albumin replacement after large-volume paracentesis: Removing greater than 5 liters without albumin (6–8 g per liter removed) causes post-paracentesis circulatory dysfunction and increases mortality.

Assuming all ascites in a cirrhotic is from cirrhosis: Approximately 5% have a second cause (malignancy, tuberculosis). Always analyze ascitic fluid — do not assume the cause even in known cirrhotics.

Overlooking cardiac causes: Cardiac ascites (heart failure, constrictive pericarditis) is the second most common cause of high SAAG ascites. Look for elevated jugular venous pressure and peripheral edema preceding ascites.

Aggressive diuresis in hepatorenal syndrome: Hepatorenal syndrome is not a volume-overloaded state — it is a vasoconstrictive response to splanchnic vasodilation. Diuretics worsen renal function; stop them and give albumin.

Delaying transplant referral: Development of ascites indicates decompensated cirrhosis with significantly reduced survival. Refer for transplant evaluation early, even if ascites is well controlled initially.

Key Takeaways

Cirrhosis accounts for approximately 85% of ascites cases in Western countries; always calculate SAAG to confirm portal hypertension is present.
Diagnostic paracentesis is the cornerstone of ascites evaluation — perform it in all new-onset cases and hospital admissions, and never withhold it due to coagulopathy.
Spontaneous bacterial peritonitis is diagnosed by ascitic polymorphonuclear cells ≥ 250/μL; start antibiotics immediately without waiting for culture.
Use the combination of SAAG and ascitic total protein to narrow the differential: high SAAG + low protein = cirrhosis; high SAAG + high protein = cardiac or Budd-Chiari; low SAAG + high protein = malignancy or tuberculosis.
First-line management of cirrhotic ascites is sodium restriction (less than 2 g/day) and dual diuretic therapy (spironolactone and furosemide in 100:40 ratio).
Albumin administration is essential: give 6–8 g per liter removed during large-volume paracentesis (greater than 5 L) and during spontaneous bacterial peritonitis treatment in high-risk patients.
Avoid NSAIDs in all patients with cirrhotic ascites — they cause diuretic resistance and precipitate renal failure.
Rising creatinine in a patient with ascites requires immediate action: hold diuretics, rule out infection, and consider hepatorenal syndrome.
Development of ascites marks the transition from compensated to decompensated cirrhosis — 5-year survival drops from approximately 80% to approximately 30%; early transplant referral is essential.
Never forget “mixed ascites” — approximately 5% of cirrhotics have a second cause; investigate if ascites behaves atypically or does not respond to standard therapy.

Quick Reference Algorithm

Systematic Approach to Ascites:

Assess urgency: Look for red flags (fever, pain, altered mental status, respiratory distress, gastrointestinal bleeding) — treat emergencies first
Perform diagnostic paracentesis: Send cell count, albumin, total protein, and culture in all cases
Calculate SAAG: Serum albumin minus ascitic albumin
- ≥ 1.1 g/dL = Portal hypertension (cirrhosis, cardiac, Budd-Chiari)
- < 1.1 g/dL = No portal hypertension (malignancy, tuberculosis, pancreatic, nephrotic)
Exclude spontaneous bacterial peritonitis: If polymorphonuclear cells ≥ 250/μL, start empiric antibiotics immediately
Obtain imaging: Abdominal ultrasound with Doppler for all; CT if malignancy or vascular cause suspected
Initiate treatment: Sodium restriction plus diuretics for cirrhotic ascites; address underlying cause for non-cirrhotic ascites
Monitor response: Daily weights, renal function, electrolytes; target 0.5–1 kg/day weight loss
Consider transplant: Refer all patients with cirrhotic ascites for transplant evaluation

High-Yield Facts for Clinical Practice

Topic	Key Fact
SAAG threshold	≥ 1.1 g/dL indicates portal hypertension with 97% accuracy
Spontaneous bacterial peritonitis diagnosis	Ascitic polymorphonuclear cells ≥ 250/μL (treat even if culture negative)
Spontaneous bacterial peritonitis prophylaxis indication	Ascitic protein less than 1.0 g/dL or prior spontaneous bacterial peritonitis episode
Diuretic ratio	Spironolactone:furosemide = 100:40 mg (maintains potassium balance)
Maximum diuretic doses	Spironolactone 400 mg/day; furosemide 160 mg/day
Weight loss targets	0.5 kg/day (ascites only); 1 kg/day (ascites plus peripheral edema)
Albumin for large-volume paracentesis	6–8 g albumin per liter removed if greater than 5 L drained
Chylous ascites definition	Ascitic triglycerides greater than 200 mg/dL (often greater than 1000 mg/dL)
Tuberculous peritonitis marker	Adenosine deaminase greater than 40 U/L (lower cutoff in cirrhosis)
Survival impact	Development of ascites reduces 5-year survival from approximately 80% to approximately 30%